Zacks Investment Research
03 Nov 2026, 17:55 UTC · 52m ago
CLB Q3 Earnings Miss Estimates on Higher Costs and Disruptions
Impact · against what's priced in
Core Laboratories faces downward pressure following a Q3 earnings miss and a significant 27.3% year-over-year decline in the bottom line. The operational squeeze is driven by a >50% drop in reservoir segment operating income due to geopolitical disruptions and rising costs, outweighing a marginal revenue beat.
- CLB−0.50
No priced-in read yet
- In context
The company missed EPS estimates (16 cents vs 17 cents expected) and saw reservoir operating income plummet from $16.6 million to $7.7 million year-over-year, highlighting a vulnerability to geopolitical disruptions.
Read from the article alone

Top 2 movers · tap to explore




